Stay updated on Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial

Sign up to get notified when there's something new on the Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The NIH announcement about website updates and the transition from “Artificial Intelligence” to “Super Intelligence” is no longer displayed above the page content.
    Difference
    1%
    Check dated 2026-11-09T14:49:49.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer’s site revision label updates from v3.7.2 to v3.8.0. The study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-11-02T16:23:51.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A banner announces updates to NIH websites and says the agency is using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-26T15:46:01.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-19T21:45:08.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-13T04:14:14.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The study page now shows a 403 error instead of the full study record, replacing the detailed trial information with an error screen. The content that users expect (title, sponsor, locations, and criteria) is not displayed.
    Difference
    20%
    Check dated 2026-09-21T22:04:09.000Z thumbnail image

Stay in the know with updates to Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial page.